Additional file 1: Figure S1. of Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib

Sorafenib increases the expression levels of MT1B in Huh7 cells. Figure S2: Pharmacological antioxidants prevent the induction of MT1B induced by sorafenib. Table S1: List of genes upregulated in Huh7 cells exposed to sorafenib (10 μM) for 9 h. Table S2: Summary of the characteristics of the hepatocellular carcinoma tumours used for short-term culture of tumour explants. Table S3: Summary of the clinical characteristics of HCC patients in the two cohorts. (DOC 185 kb

Additional file 2: of Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib

Supplementary materials and methods. (DOC 44 kb